The present study, for the first time, identified a novel pivotal role of MSI2 in inhibiting CRC ferroptosis: it mainly promotes MAPKAPK2-HSPB1 axis phosphorylation through interacting with P-ERK and then activating the p38-MAPK signaling pathway (Fig. 9). Here, MAPKAPK2 is linked to colorectal carcinoma.